Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs AMCR✓SelectedUSD · AMCRGSK vs AMCR performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs AMCR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
AMCR return
+14.7%
Excess return
+82.3%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioAMCRExcessAlpha
1D-0.1%-0.3%+0.1%-0.1%
7D-5.3%-3.3%-2.0%-4.5%
30D-3.7%-6.5%+2.8%-2.0%
3M-7.3%-10.1%+2.9%-4.7%
6M-4.2%+14.7%-18.9%-7.8%
YTD+0.9%+6.1%-5.2%-1.4%
1Y+7.3%+7.5%-0.2%+4.6%
3Y+52.7%+6.5%+46.2%+47.8%
5Y+40.1%-8.6%+48.7%+39.6%
All+97.1%+14.7%+82.3%+74.0%

Cumulative growth

Daily Returns

Daily percentage return beside AMCR.

Daily Out/Under-Performance

Portfolio return minus AMCR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × AMCR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded AMCR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling